Mechanisms of Pharmacokinetic Enhancement Between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (p-Glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs

We investigated the mechanisms of ritonavir‐mediated enhancement effect on the pharmacokinetics of saquinavir using in vivo probes for CYP3A4 (midazolam), p‐glycoprotein (fexofenadine), and OATP1B1 (pravastatin) following oral micro/small dosing. A cocktail of the drugs (2 mg of saquinavir, 100 µg o...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical pharmacology Vol. 53; no. 6; pp. 654 - 661
Main Authors: Ieiri, Ichiro, Tsunemitsu, Shyohei, Maeda, Kazuya, Ando, Yukie, Izumi, Noritomo, Kimura, Miyuki, Yamane, Naoe, Okuzono, Tsuyoshi, Morishita, Mariko, Kotani, Naoki, Kanda, Eri, Deguchi, Mariko, Matsuguma, Kyoko, Matsuki, Shunji, Hirota, Takeshi, Irie, Shin, Kusuhara, Hiroyuki, Sugiyama, Yuichi
Format: Journal Article
Language:English
Published: England Blackwell Publishing Ltd 01-06-2013
American College of Clinical Pharmacology
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first